Shortage of Bicillin-LA (benzathine penicillin G)

["Centers for Disease Control & Prevention" <cdc@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Shortage of Bicillin-LA (benzathine penicillin G)

Having trouble viewing this email? View it as a Web page.

CDC was recently notified of difficulties in obtaining Bicillin-LA (benzathine penicillin G). Benzathine penicillin G is the recommended treatment for syphilis and the only treatment option for pregnant women infected with or exposed to syphilis. The recommended treatments for syphilis are outlined in 2015 STD Treatment Guidelines along with alternative regimens.

For more information on the shortage, see Bicillin-LA (benzathine penicillin G) Shortage .

---

Stay in touch with the Division of STD Prevention by following us on Twitter and Facebook

  

CDC's STD Web Site

---

The CDC has reached over 1 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support@xxxxxxxxxxxxxxx.

 

   

---

This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery,on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636)